ABBVIE INC. (ABBV)
Underlying price
$265.00+0.39% today
Stock stats
- Market cap
- $466B
- Previous close
- $263.96
- Open
- $263.07
- Day's range
- $261.23 – $266.59
- 52-week range
- $190.75 – $267.47
- Volume
- 1.72M
- Avg volume
- 4.43M
- P/E ratio
- 74.16
About ABBVIE INC.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
- Ticker
- ABBV
- Asset class
- Equity
- Tokenized by
- 2 issuers
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Employees
- 57,000
- Website
- abbvie.com
ABBVIE INC. FAQ
ABBV is ABBVIE INC. stock, issued on Solana as a token that tracks the listed share. Each issuer mints its own version, so ABBVIE INC. trades here as 2 tokens rather than one.